3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
43
Head and Neck Neoplasms
35
Nasopharyngeal Carcinoma
19
Oropharyngeal Neoplasms
17
Carcinoma, Squamous Cell
15
Rectal Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Prostatic Neoplasms
11
Esophageal Squamous Cell Carcinoma
11
Mouth Neoplasms
8
Esophageal Neoplasms
8
Pancreatic Neoplasms
7
Laryngeal Neoplasms
7
Sarcoma
6
Tongue Neoplasms
5
Papillomavirus Infections
5
Lung Neoplasms
5
Hypopharyngeal Neoplasms
5
Glioblastoma
5
Brain Neoplasms
5
Stomatitis
4
Neoplasm Metastasis
4
Nasopharyngeal Neoplasms
4
Carcinoma
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Thyroid Carcinoma, Anaplastic
3
Lymphatic Metastasis
3
Gliosarcoma
3
Glioma
3
Interventions
Carboplatin
2
tislelizumab
1
epigallocatechin gallate
1
Tablets
1
Range of Motion, Articular
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Pravastatin
1
Paclitaxel
1
Lead
1
Fibroblast Growth Factor 7
1
Esophagectomy
1
Cisplatin
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Deglutition Disorders
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05596890
2022-11-28
PICCRT
Guangdong Provincial People's Hospital
Phase 2
Unknown
50 enrolled